Adcetris 50mg

Adcetris (Brentuximab vedotin)

Brand Name: Adcetris
Active Ingredient: Brentuximab vedotin
Dosage Form: 150mg / vial
Manufacturer Name: Takeda
Adcetris 50 mg is a chemotherapeutic medication used to treat cancer. An anti-­neoplastic agent and a monoclonal antibody are assigned to these medications. Adults with certain types of lymphoma can be treated with Adcetris brentuximab vedotin. A type of cancer known as lymphoma affects your lymphatic system and particular white blood cells known as lymphocytes. The cost of brentuximab vedotin is modest.
website background
Doctor

Why is Brentuximab Vedotin prescribed?

Adcetris is a chemotherapeutic medication that fights cancer (“antineoplastic” or “cytotoxic”) and is available only by prescription.


Patients with Hodgkin’s lymphoma (Hodgkin’s disease) who have not previously had treatment, as well as those who are vulnerable to the condition getting worse or coming back after a stem cell transplant, are treated with injections of brentuximab vedotin together with other chemotherapy medications which is a procedure that replaces diseased bone marrow with healthy bone marrow.


A monoclonal antibody, or kind of protein, found in the Adcetris active ingredient, brentuximab vedotin, binds to CD30 and the cytotoxic (cell-killing) chemical monomethyl auristatin E. To treat leukemias that are CD30-positive, monoclonal antibodies produce monomethyl auristatin E.

Following the entry of the cytotoxic chemicals, the cancer cells stop dividing and finally die. Get brentuximab injection at the best price in UAE from us, HAYAT ALHIKMAH, through Name patient Import Services or Govt Hospital Supply.

The suggested dosage is 1.8 mg/kg given as a 30-minute intravenous infusion every three weeks. Before administering each dose of this medicine, complete blood counts should be checked. Patients need to be examined both during and after an infusion.

Who should not take Brentuximab Vedotin?

If you’re unsure, speak with your doctor.

What are the possible side effects of Brentuximab Vedotin?

Severe possible side effects of Brentuximab Vedotin include:

Special Precautions For Kineret

About Us

We are a leading pharmaceutical wholesaler, Hayat Alhikmah, situated in Dubai. By providing generic medications, reference listed drugs, name patient import services, and temperature-controlled products simple to access for our consumers, we help them overcome geographic distances.

We offer affordable access to adcetris injection in Dubai with ease and speed. Depending on the customer’s needs, we provide a quality guarantee and shipping anywhere in the world.

Please schedule a consultation with us by calling us at +971 54 777 1238 or +971 55 223 1090 or email us at [email protected] to know how much Brentuximab Vedotin injection costs in Dubai. Our helpful team would be happy to assist you and provide any general or medical information.
0 +

Distributors

0 +

Ware House

0 +

Awards

FAQ's

A drug used to treat cancer is called brentuximab. Also, it goes by the brand name Adcetris; its full name is brentuximab vedotin. It is a therapy for Hodgkin lymphoma, cutaneous T cell lymphoma, anaplastic large cell lymphoma, and a non-Hodgkin lymphoma subtype. Monoclonal antibodies include brentuximab. These medicines are created in laboratories. These medicines will target specific proteins on the cell surface. Monoclonal antibodies look for cancer cells. Anaplastic large-cell lymphoma and Hodgkin lymphoma cells contain a protein called CD30, the target of the drug brentuximab. To deliver medicine to the cell, brentuximab adheres to the CD30 protein. After that, the medication kills the cell.

For some kids and teenagers with Hodgkin lymphoma, it could be able to curtail or even do away with the need for radiation therapy. In a recent study, the targeted medication brentuximab vedotin was used in place of one chemotherapy agent as the initial treatment for kids and teenagers with a high-risk variant of Hodgkin lymphoma. The adjusted therapy significantly decreased the need for radiation therapy among study participants while being very effective against malignancy. A well-known first or first-line treatment regimen for high-risk juvenile Hodgkin lymphoma was used in the trial. However, brentuximab was used in place of the chemotherapeutic agent vincristine. When necessary, radiation treatment is used after combinations of several chemotherapy medications.

Blood malignancies Hodgkin lymphoma, systemic anaplastic large cell lymphoma, and primary cutaneous anaplastic large cell lymphoma are all treated with the injection of brentuximab. A specialist injects this medicine over 30 minutes into a vein. It is administered as your doctor instructs, typically once every three weeks. Your weight, medical history, and treatment response determine the dosage. Throughout the infusion, your healthcare provider will keep an eye on you if you experience a brentuximab reaction. If a less severe reaction happens, the injection will be stopped, the response will be treated, and the infusion will resume. Depending upon the reaction of the drug, the dosage will be adjusted by your doctor.

Hodgkin lymphoma, systemic anaplastic large cell lymphoma, and primary cutaneous anaplastic large cell lymphoma are all blood malignancies treated by the injection of brentuximab. Patients who underwent unsuccessful cancer treatments, such as bone marrow transplants, are treated with this medicine. Stage III or stage IV classical Hodgkin lymphoma can also be treated with a brentuximab injection and other cancer medications. Patients with sALCL or other peripheral T-cell lymphomas that express CD30 may also receive combination therapy with a brentuximab injection and additional drugs. The proliferation of cancer cells is slowed down by brentuximab, and the body ultimately eliminates them. Only your doctor, acting directly under their direction, may provide this medication.

Adcetris is a chemotherapeutic medication that fights cancer (“antineoplastic” or “cytotoxic”) and is available only by prescription.

Patients with Hodgkin’s lymphoma (Hodgkin’s disease) who have not previously had treatment, as well as those who are vulnerable to the condition getting worse or coming back after a stem cell transplant, are treated with injections of brentuximab vedotin together with other chemotherapy medications which is a procedure that replaces diseased bone marrow with healthy bone marrow.

A monoclonal antibody, or kind of protein, found in the Adcetris active ingredient, brentuximab vedotin, binds to CD30 and the cytotoxic (cell-killing) chemical monomethyl auristatin E. To treat leukemias that are CD30-positive, monoclonal antibodies produce monomethyl auristatin E.

  •  Those who are allergic to any of the ingredients in brentuximab vedotin.
  •  The patient information sheet’s final section includes a detailed list of the constituents in brentuximab vedotin.
  •  Women who are breastfeeding or pregnant.
  •  If one has kidney disease that might affect kidney functioning.
If you’re unsure, speak with your doctor.
Severe possible side effects of Brentuximab Vedotin include:

Severe possible side effects of Brentuximab Vedotin include: